A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients

Joseph A. Caprini; Maryanne Cronin; Nancy Dengler; Eugene Krauss

doi:10.1055/a-2174-0963

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2024; 124(03): 236-238
DOI: 10.1055/a-2174-0963

Invited Editorial Focus

A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients

Authors

Joseph A. Caprini

¹Emeritus Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States

²Pritzker School of Medicine, Chicago, Illinois, United States
Maryanne Cronin

³Orthopaedic Surgery, Syosset Hospital, Northwell Health, Syosset, New York, United States
Nancy Dengler

³Orthopaedic Surgery, Syosset Hospital, Northwell Health, Syosset, New York, United States
Eugene Krauss

³Orthopaedic Surgery, Syosset Hospital, Northwell Health, Syosset, New York, United States

Abstract

Volltext

Referenzen

References
1 Krauss ES, Segal A, Cronin M. et al. Implementation and validation of the 2013 Caprini score for risk stratification of arthroplasty patients in the prevention of venous thrombosis. Clin Appl Thromb Hemost 2019; 25: 1076029619838066
2 Qiao L, Yao Y, Wu D. et al. The validation and modification of the Caprini risk assessment model (RAM) for evaluating venous thromboembolism (VTE) after joint arthroplasty. Thromb Haemost 2024; 124 (03) 223-235
3 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2–3): 70-78
4 Lobastov K, Urbanek T, Stepanov E. et al. The thresholds of Caprini score associated with increased risk of venous thromboembolism across different specialties: a systematic review. Ann Surg 2023; 277 (06) 929-937
5 Singh G, Prentice HA, Winston BA, Kroger EW. Comparison of 90-day adverse events associated with aspirin and potent anticoagulation use for venous thromboembolism prophylaxis: a cohort study of 72,288 total knee and 35,142 total hip arthroplasty patients. J Arthroplasty 2023; 38 (08) 1602.e1-1612.e1
6 Sidhu VS, Kelly TL, Pratt N. et al; CRISTAL Study Group. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA 2022; 328 (08) 719-727
7 Krauss ES, Segal A, Dengler N, Cronin M, Pettigrew J, Simonson BG. Utilization of the Caprini score for risk stratification of the arthroplasty patient in the prevention of postoperative venous thrombosis. Semin Thromb Hemost 2022; 48 (04) 407-412
8 Zhuang Q, He Q, Aikebaier A, Chen W, Liu J, Wang D. The risk factors for new-onset calf muscle venous thrombosis after hip fracture surgery. J Pers Med 2023; 13 (02) 257
9 Johanson NA, Lachiewicz PF, Lieberman JR. et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg 2009; 17 (03) 183-196
10 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e278S-e325S
11 Luksameearunothai K, Sa-Ngasoongsong P, Kulachote N. et al. Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures. BMC Musculoskelet Disord 2017; 18 (01) 208